Kirkland Advises Carlyle on $3.8B Acquisition of Baxter's Kidney Care Segment
August 14, 2024
August 14, 2024
CHICAGO, Illinois, Aug. 14 -- Kirkland and Ellis, a law firm, issued the following news release:
Kirkland & Ellis is advising global investment firm Carlyle (NASDAQ: CG) on the $3.8 billion acquisition of global medtech company Baxter International Inc.'s (NYSE:BAX) kidney care segment, which will be named Vantive.
The transaction was announced on August 13, 2024. Under the terms of the definitive agreement, subject to certain closing adjustments, Baxter will receiv . . .
Kirkland & Ellis is advising global investment firm Carlyle (NASDAQ: CG) on the $3.8 billion acquisition of global medtech company Baxter International Inc.'s (NYSE:BAX) kidney care segment, which will be named Vantive.
The transaction was announced on August 13, 2024. Under the terms of the definitive agreement, subject to certain closing adjustments, Baxter will receiv . . .